Adverse effects: 5 most common adverse effects (any age) – accidental injury · people with drug‐resistant focal epilepsy
Levetiracetam showed no clear difference in adverse effects: 5 most common adverse effects (any age) –… compared with placebo (low certainty).
1 finding from 1 review
Risk for at least one adverse event per patient · People with American cutaneous and mucocutaneous leishmaniasis
Meglumine antimoniate (IMMA) (20 mg/kg/d for 20 days) probably leads to higher adverse effects (number of participants who had at least one adverse… compared with placebo (3 tablets/4 times a day (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse effects considered as serious by either the patient or the clinician · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Leaving the study early ‐ due to adverse effects (short term) · patients with schizophrenia
It is very uncertain whether CHLORPROMAZINE changes leaving the study early due to adverse effects ‐ short term (up to 6… compared with RISPERIDONE (very low certainty).
1 finding from 1 review
Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: 2. Extrapyramidal ‐ akathisia · patients with schizophrenia
ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS may leads to lower adverse effects: Extrapyramidal symptoms ‐ specific ‐ akathisia… compared with STANDARD DOSE ANTIPSYCHOTICS (low certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE probably leads to lower adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson… compared with RISPERIDONE (moderate certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE may leads to lower adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson… compared with ZIPRASIDONE (low certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson medication · schizophrenia
QUETIAPINE showed no clear difference in adverse effects: 2. Extrapyramidal effects ‐ use of antiparkinson… compared with ARIPIPRAZOLE (low certainty).
1 finding from 1 review
B4: Discontinuation of therapy due to maternal adverse effects – an all women · the woman
1 finding from 1 review
Clinically important adverse effects other than central nervous system or EPS · schizophrenia spectrum disorders with catatonic symptoms
1 finding from 1 review
Adverse effect: fatigue · people with drug‐resistant focal epilepsy
Levetiracetam showed no clear difference in adverse effects: 5 most common adverse effects (any age) – fatigue… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects on women: faecal incontinence during first 10 postpartum days · postpartum women who underwent surgical repair of third degree perineal tears
It is very uncertain whether laxative plus bulking agent changes adverse effects on women: faecal incontinence during first 10… compared with laxative alone (very low certainty).
1 finding from 1 review
Adverse effects associated with hormones:Bleeding/spotting Nausea Weight gain · endometrial hyperplasia
It is very uncertain whether LNG‐IUS changes adverse effects associated with hormones:Bleeding/spotting Nausea… compared with non‐intrauterine progestogen (very low certainty).
1 finding from 1 review
Adverse effects. Specific: movement disorders ‐ parkinsonism · patients with schizophrenia
It is very uncertain whether chlorpromazine changes adverse effects/events: clinically important movement disorder… compared with piperacetazine (very low certainty).
1 finding from 1 review
Adverse effects – leaving the study early due to adverse effects – overall tolerability – total · non response in schizophrenia
It is very uncertain whether antipsychotic dose increase changes leaving the study early: tolerability ‐ leaving early due to adverse… compared with antipsychotic dose continuation (very low certainty).
1 finding from 1 review
Adverse events ‐ specific side effects attributed to oestrogen over 8 months' · women with PMS
It is very uncertain whether dose comparison: oestrogen 100 µg patch changes adverse events ‐ specific side effects attributed to oestrogen over… compared with 200 µg patch plus progestogen (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: Acupressure versus placebo , no treatment or active controls · women with primary dysmenorrhoea
The review found no eligible studies for this question.
1 finding from 1 review